Yüklüyor......

Iron Chelation Therapy in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are a heterogeneous disorder of the hematopoietic stem cells, frequently characterized by anemia and transfusion dependency. In low-risk patients, transfusion dependency can be long lasting, leading to iron overload. Iron chelation therapy may be a therapeutic option...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Messa, Emanuela, Cilloni, Daniela, Saglio, Giuseppe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2905902/
https://ncbi.nlm.nih.gov/pubmed/20672005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/756289
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!